Schedule 13D ownership disclosure
NEWAMSTERDAM PHARMA COMPANY
Security class unavailable · CUSIP: N62509109
Event date: 2024-12-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-280208
- Form type
- SC 13D
- Filer
- Frazier Life Sciences X, L.P.
- CIK
- CIK 1790879
- Filed
- Dec 17, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13D beneficial ownership